ENB Therapeutics’ Orphan Drug, Endothelin Receptor Type B Target for Resistant Cancers February 15, 2023
2 Women-Founded Companies are Optimizing Targeted Lipid Nanoparticle mRNA Therapies for a Rare Respiratory DiseaseFebruary 3, 2023
All Archives BIO’s New CEO Michelle McMurry-Heath- Exemplifying the Diverse Biotech EcosystemBy Biotech Metropolitan WomenJune 12, 2020At a time when most companies are challenged with planning their initial diversity and inclusion dialogues, The Biotechnology Innovation Organization… Read More
All Archives Where The Women Are Networking At JP Morgan Healthcare ConferenceBy Veta ObazenuJanuary 10, 2020At the start of the new year, industry professionals travel far and wide to make their appearance at the JP… Read More
All Archives Trending at the 38th Annual JP Morgan Healthcare Conference| MedTech, M&A, Biosimilars, ChinaBy Veta ObazenuJanuary 10, 2020This year marks a new decade and the 38th annual JP Morgan Healthcare conference at the Westin St. Francis. The… Read More
All Archives How Do You Define Power? Crain’s 2019 Most Powerful Women in New York LuncheonBy Biotech Metropolitan WomenSeptember 19, 2019Crain’s New York Business published their 2019 list of Most Powerful Women in New York this past June. The list… Read More
All Archives ESG, SRI and Impact Investing: Women as Benefactors and Beneficiaries in RIBy Biotech Metropolitan WomenAugust 31, 2019Responsible Investing (RI) has increasingly become a rule for today’s socially conscience capitalists that want to implement their value set… Read More
